Molecular pathogenesis of endometriosis-associated clear cell carcinoma of the ovary (Review)
This review discusses the molecular pathogenesis of endometriosis-associated ovarian clear cell carcinoma, highlighting oxidative stress from iron and heme leading to genetic damage and alterations in genes like PTEN, APC, p53, and K-RAS.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
This review examines the molecular mechanisms underlying endometriosis-associated ovarian clear cell carcinoma (CCC), using an English-language literature synthesis of studies including LOH/allelic loss, comparative genomic hybridization, mutation, methylation, microarray gene-expression profiling, and proteomics. It highlights that retrograde menstruation or ovarian hemorrhage can introduce pro-oxidant heme and iron, and that iron-dependent oxidative stress in histologically normal ectopic endometrium may drive DNA damage and LOH as a critical carcinogenic factor. LOH studies point to multiple implicated chromosomal regions (5q, 6q, 9p, 10q, 11q, 17q, and 22q), and the review discusses potential involvement of genes including PTEN and APC (early events) and p53, polo-like kinases, Emi1, and K-RAS (late events), while emphasizing that CCC molecular pathology is heterogeneous with possible multiple precursor lesions and pathways. As an overview of existing studies, it does not present new experimental data. This paper is centrally about endometriosis — it specifically reviews the molecular pathogenesis of endometriosis-associated clear cell carcinoma of the ovary.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
Full text
4,567 characters
· extracted from
oa-doi-fallback
· click to expand
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (49)
- Activation of mammalian target of rapamycin in postmenopausal ovarian endometriosis via openalex
- Cellular and genetic constitution of human endometriosis tissues via openalex
- Common Genetic Changes between Endometriosis and Ovarian Cancer via openalex
- Contents of Endometriotic Cysts, Especially the High Concentration of Free Iron, Are a Possible Cause of Carcinogenesis in the Cysts through the Iron-Induced Persistent Oxidative Stress via openalex
- Endometriosis and the neoplastic process via openalex
- Endometriosis and the risk of cancer with special emphasis on ovarian cancer via openalex
- Increased prevalence of p53 overexpression from typical endometriosis to atypical endometriosis and ovarian cancer associated with endometriosis via openalex
- Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary. via openalex
- Malignant transformation of endometriosis and genetic alterations of K‐ras and microsatellite instability via openalex
- Microsatellite analysis of endometriosis reveals loss of heterozygosity at candidate ovarian tumor suppressor gene loci. via openalex
- Microsatellite DNA assays reveal an allelic imbalance in p16Ink4, GALT, p53, and APOA2 loci in patients with endometriosis via openalex
- Molecular Genetic Defects in Endometriosis via openalex
- Molecular genetic evidence that endometriosis is a precursor of ovarian cancer via openalex
- Molecular mechanisms and biological plausibility underlying the malignant transformation of endometriosis: a critical analysis via openalex
- Oxidative stress and peritoneal endometriosis via openalex
- Patterns of Loss of Heterozygosity at 10q23.3 and Microsatellite Instability in Endometriosis, Atypical Endometriosis, and Ovarian Carcinoma Arising in Association With Endometriosis via openalex
- Risk of developing ovarian cancer among women with ovarian endometrioma: a cohort study in Shizuoka, Japan via openalex
- Role of Iron in the Pathogenesis of Endometriosis via openalex
- Role of K-ras and Pten in the Development of Mouse Models of Endometriosis and Endometrioid Ovarian Cancer via openalex
- Somatic DNA alterations in endometriosis: high frequency of chromosome 17 and p53 loss in late-stage endometriosis via openalex
- The Role of p53 Mutation in the Carcinomas Arising from Endometriosis via openalex
- doi:10.1016/s1077-9108(08)70624-8 via openalex
- doi:10.1038/ncb785 via openalex
- doi:10.1002/(sici)1097-0142(19990201)85:3<669::aid-cncr17>3.0.co;2-f via openalex
- doi:10.3109/14733400500422008 via openalex
- doi:10.1016/0169-5002(90)90304-5 via openalex
- doi:10.1097/01.pap.0000201828.92719.f3 via openalex
- doi:10.1007/s00795-003-0233-0 via openalex
- doi:10.1016/j.mrfmmm.2003.08.023 via openalex
- W1505255521 via openalex
- doi:10.1111/j.1349-7006.2008.01001.x via openalex
- doi:10.1038/modpathol.3800492 via openalex
- doi:10.1097/pas.0b013e3181788546 via openalex
- doi:10.1093/molehr/gan033 via openalex
- doi:10.1007/s10552-007-9058-9 via openalex
- doi:10.1258/136218006777525794 via openalex
- doi:10.1002/path.2386 via openalex
- doi:10.1023/b:mcbi.0000049134.69131.89 via openalex
- doi:10.1038/366704a0 via openalex
- doi:10.1158/1078-0432.ccr-08-1387 via openalex
- doi:10.1016/j.fertnstert.2008.01.041 via openalex
- doi:10.1007/s00428-007-0543-z via openalex
- doi:10.1038/modpathol.3801022 via openalex
- doi:10.1038/sj.onc.1203463 via openalex
- doi:10.1152/ajpcell.00422.2001 via openalex
- doi:10.1038/bjc.1996.491 via openalex
- doi:10.1038/sj.onc.1209821 via openalex
- doi:10.1007/978-1-4020-5133-3_14 via openalex
- doi:10.1093/bfgp/elm007 via openalex
Cited by (15)
- Endometriosis: assessment on O-RADS and risk of malignant transformation 2025
- Histologic Subtypes in Endometriosis-Associated Ovarian Cancer and Ovarian Cancer Arising in Endometriosis: A Systematic Review and Meta-Analysis 2024
- Factors in malignant transformation of ovarian endometriosis: A narrative review 2024
- Ribosome Biogenesis Serves as a Therapeutic Target for Treating Endometriosis and the Associated Complications 2022
- Role of inflammation in benign gynecologic disorders: from pathogenesis to novel therapies† 2021
- Integrating modern approaches to pathogenetic concepts of malignant transformation of endometriosis 2018
- BAF250a Expression in Atypical Endometriosis and Endometriosis-Associated Ovarian Cancer 2016
- Molecular Pathogenesis of Ovarian Clear Cell Carcinoma 2015
- Checkpoint kinase 1 inhibitors as targeted molecular agents for clear cell carcinoma of the ovary 2015
- Endometriosis-Associated Ovarian Cancer: A Review of Pathogenesis 2013
- Cellular, Histologic, and Molecular Changes Associated With Endometriosis and Ovarian Cancer 2013
- Association of TP53 gene codon 72 polymorphism with endometriosis in Mexican women 2012
- Identification of multiple pathways involved in the malignant transformation of endometriosis (Review) 2012
- Pathogenesis of Ovarian Clear Cell Adenofibroma, Atypical Proliferative (Borderline) Tumor, and Carcinoma: Clinicopathologic Features of Tumors with Endometriosis or Adenofibromatous Components Support Two Related Pathways of Tumor Development 2011
- Risk of carcinoma in women with ovarian endometrioma 2010
Source provenance
- openalex
- last seen: 2026-05-13T17:53:53.142783+00:00